Abstract
In patients with iron deficiency anemia (IDA), intravenous iron (IVI) is the preferred and most efficacious treatment when oral iron cannot be used or where rapid iron delivery is required; however, IV infusions are burdensome for patients and require them to travel to specialist infusion units, which can have a detrimental effect on patient quality of life (QoL). Also, the number of visits varies greatly between different IVI formulations. The aim of the present study was to quantify the magnitude of the effect of different annual infusion rates on QoL.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
